AUG 07, 2016 6:25 AM PDT

Making Drugs from Yeast, On the Go!

WRITTEN BY: Xuan Pham
When we need medicine, we hop down to the local drugstore or pharmacy and have our prescriptions filled. But what happens when doctors or emergency responders are in remote areas with limited time and limited access? Where’s their pharmacy?
 
MIT researchers tackled this problem by developing a portable unit that’s capable of producing drugs on demand. The concept is similar to another prototype that was developed by a group, also at MIT, earlier this year. However, the current portable pharmacy runs on yeast.

Yes, yeast. Specifically, yeast of the Pichia pastoris strain.

Portable pharmacy uses yeast to make drugs | Image: MIT
 
In their paper, published in Nature Communications, the team detailed how a small drop of yeast cells suspended in liquid can act as a bioreactor, manufacturing a single dose of a drug. “We altered the yeast so it could be more easily genetically modified, and could include more than one therapeutic in its repertoire,” said Timothy Lu, head of the Synthetic Biology Group at MIT’s Research Laboratory of Electronics, and senior author of the study.
 
The yeast is modified to express therapeutic proteins upon exposure to different chemical stimuli. These cells are also low maintenance in terms of food and care, but can express a large amount of proteins, making them ideal as natural bioreactors.
 
“Imagine you were on Mars or in a remote desert, without access to a full formulary, you could program the yeast to produce drugs on demand locally,” Lu said.

Of course using cells as bioreactors has been widely exploited by nearly every pharmaceutical company. The genius in Lu’s research lays in compressing the entire process into a microbioreactor that’s entirely portable and requires a tiny amount of cells. The magic involves a microfluidic chip that receives the chemical trigger and sends it to the yeast. Then, pressurized gas ensures the mixing process is efficient and complete.
 
“This makes sure that the one milliliter (of liquid) is homogenous, and that is important because diffusion at these small scales, where there is no turbulence, takes a surprisingly long time,” said Rajeev Ram, the MIT professor who developed the microfluidic chip, and senior co-author of the study.
 
Researchers monitor the environment of the cells at all time, and they can change what proteins the yeast are producing by flushing in new liquid with different chemical triggers. “You want to keep the cells because they are your factory,” said Ram. “But you also want to rapidly change their chemical environment, in order to change the trigger for protein production.”
 
Next, in addition to refining the system, the team is looking for even more capabilities for the microreactors. “If you could engineer a single strain, or maybe even a consortia of strains that grow together, to manufacture combinations of biologics or antibodies, that could be a very powerful way of producing these drugs at a reasonable cost,” said Lu.
 


Additional source: MIT news release
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
MAY 18, 2021
Genetics & Genomics
Library Prep Methods for SARS-CoV-2 Sequencing: a Summary
MAY 18, 2021
Library Prep Methods for SARS-CoV-2 Sequencing: a Summary
As the SARS-CoV-2 virus continues to mutate, rapid sequencing of COVID-19-positive samples is more critical than ever. N ...
JUL 27, 2021
Clinical & Molecular DX
Thumb-Sized Device Tells You if Your Breath Stinks
JUL 27, 2021
Thumb-Sized Device Tells You if Your Breath Stinks
People generally can’t smell their own breath. So, for individuals with halitosis—or bad breath—friend ...
AUG 08, 2021
Cardiology
Strong Links Between PTSD and Heart Disease
AUG 08, 2021
Strong Links Between PTSD and Heart Disease
The link between heart disease and stress is well known, but researchers still have a lot to learn about that associatio ...
AUG 19, 2021
Clinical & Molecular DX
Biosensor Illuminates Growing Tumors and Healing Wounds
AUG 19, 2021
Biosensor Illuminates Growing Tumors and Healing Wounds
Cancerous tissues can be difficult to spot, particularly at the early stages. The malignant cells are sometimes indistin ...
SEP 14, 2021
Clinical & Molecular DX
HIV Self-Test App Proves Promising
SEP 14, 2021
HIV Self-Test App Proves Promising
A new app allows users to self-test for HIV, which has proven to help positive patients get access to medical care and c ...
SEP 16, 2021
Clinical & Molecular DX
Medical Opinions Are Often Divided, but Tech Can Bring Them Together
SEP 16, 2021
Medical Opinions Are Often Divided, but Tech Can Bring Them Together
Patients place their faith in medical professionals for making sound clinical decisions based on their diagnoses. But wh ...
Loading Comments...